Duloxetine and walking exercise for veterans with knee osteoarthritis and low mood
Tests duloxetine with an exercise program in veterans with knee osteoarthritis and depression.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Baltimore, United StatesSee the site
- Trial code
- Registry title
- Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 102 people, planned
- Starts
- 1 Mar 2027
- Expected to end
- 1 Sept 2032
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Exercise
- Duloxetine
- Placebo
- PT referral
- Record updated
- 16 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Veterans aged 40 or older with painful knee osteoarthritis and depressive symptoms. It tests duloxetine and an aerobic walking program.
- Age
- 40 years and older
- Sex
- All sexes
- Disease stage
- Knee osteoarthritis with symptoms, based on American College of Rheumatology (ACR) criteria. Mild to severe depressive symptoms on the PHQ-9 questionnaire.
- Earlier treatment
- People currently using antidepressants, opioids, benzodiazepines or antipsychotics cannot join. People doing structured aerobic or strength exercise 3 or more times per week cannot join.
Main reasons for not taking part
- Knee surgery planned within the next 6 months
- Memory or thinking problems with an MMSE score below 20
- Bipolar disorder, psychosis, recent substance use disorder, or suicidal thoughts
- Health problems that make exercise unsafe, such as a recent heart attack or blood pressure above 190/110
- Pregnant or breastfeeding, or cancer now treated with chemotherapy or radiation
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Veterans aged ≥40 years
- English-speaking
- symptomatic KOA based on American College of Rheumatology (ACR) criteria
- Patient Health Questionnaire-9 (PHQ-9) scores indicating mild to severe depressive symptoms
- no planned knee surgery within the next 6 months
- ability to participate in supervised aerobic exercise
Who cannot take part
- active cancer that is currently undergoing treatment (receiving chemotherapy and/or radiation therapy
- cognitive impairment defined as a Mini-Mental State Examination (MMSE) score <20
- diagnosis of bipolar disorder, psychosis, recent substance use disorder, or suicidal ideation per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
- medical conditions contraindicating exercise (e.g., recent myocardial infarction, unstable angina, peripheral arterial disease with ulcers, -uncontrolled hypertension >190/110, or New York Heart Association class ≥3 cardiac or pulmonary disease)
- other conditions deemed by study team to endanger the health of the participant
- current use of antidepressants, opioids, benzodiazepines, or antipsychotics
- engaging in structured aerobic or resistance exercise ≥3 times per week
- pregnant or lactating individuals
Where in United States
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MDBaltimore, United StatesContact: Alice S Ryan, PhDNot yet recruiting
About the trial
What the trial wants to find out
Knee osteoarthritis (KOA) is one of the most common causes of chronic pain, mobility problems, and disability among United States Veterans. Many Veterans with KOA also experience depressive symptoms, which can worsen pain, reduce motivation to exercise, and make recovery more difficult. This study will test whether a structured hybrid aerobic exercise program that combines supervised and home-based walking with the medication duloxetine can improve physical function, reduce pain, lessen depressive symptoms, and improve overall health-related outcomes in Veterans with KOA. The goal of this research is to develop a practical and scalable treatment strategy that could improve rehabilitation and quality of life for Veterans with chronic knee pain and depressive symptoms and potentially be adapted for other chronic musculoskeletal conditions treated within the VA healthcare system.
The 3 groups in the trial
- Exercise+DuloxetineExisting treatment, for comparison
hybrid supervised aerobic exercise plus duloxetine
Treatment: Exercise and Duloxetine
- Duloxetine+PT referralExisting treatment, for comparison
duloxetine plus physical therapy (PT) referral
Treatment: Duloxetine and PT referral
- Exercise+PlaceboExisting treatment, for comparison
hybrid supervised aerobic exercise plus placebo
Treatment: Exercise and Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Duloxetine Plus Exercise to Improve Physical Function in Veterans With Knee Osteoarthritis, Pain, and Psychological Comorbidity
- Plain-language title
- Duloxetine and walking exercise for veterans with knee osteoarthritis and low moodGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 16 June 2026